Strand Therapeutics is a clinical-stage biotech company developing mRNA therapeutics for cancer and autoimmune diseases.
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Strand Therapeutics is a clinical-stage biotech company developing mRNA therapeutics for cancer and autoimmune diseases.
Zag Bio is a development stage biotechnology company focused on developing therapeutics to treat autoimmune diseases by training tissue-specific T regulatory cells to enable toler…
Infinimmune systematically surfaces and engineers rare antibodies proven effective in humans, advancing them into clinical trials. They utilize a proprietary platform to discover…
Arsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on solid tumor cell therapies to defeat cancer.
City Therapeutics is a biopharmaceutical company harnessing next-generation engineering of RNAi trigger molecules to improve and expand the reach of RNAi-based medicines. The comp…
Iambic Therapeutics is developing superior medicines through an AI-driven platform that tackles challenging design problems in drug discovery, focusing on optimizing drug candidat…
TRIANA Biomedicines is a venture-backed biopharmaceutical company leading a transformative approach to discover and develop novel therapeutics to treat diseases. The company focus…
Think Bioscience develops small-molecule drugs for historically challenging targets by using synthetic biology to uncover novel mechanisms of biomolecular engagement.
Coultreon Biopharma is focused on developing life-changing medicines for patients affected by chronic inflammatory diseases, leveraging expertise in immunology and drug discovery…